*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
R9720 - Elevated prostate specific antigen [PSA] - as a primary diagnosis code | R9720 - Elevated prostate specific antigen [PSA] - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 5.15 | |
Readmission Rate (%) | 16.82 | |
Unplanned Readmission Rate (%) | NA | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,808,415 | ||||
Total Hospitalizations with ICD R9720 - Elevated prostate specific antigen [PSA] | 785 | ||||
DRG Share of Total Hospitalizations | 5.5 | ||||
% of Total ICD R9720 - Elevated prostate specific antigen [PSA] in DRG | 4.95 | ||||
Avg LOS at DRG | 6.34 | ||||
Avg LOS with ICD R9720 - Elevated prostate specific antigen [PSA] | 6.64 | ||||
Readmission Rate at DRG | 24.2 | ||||
Readmission Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 19.91 | ||||
Unplanned Readmission Rate at DRG | 16.78 | ||||
Unplanned Readmission Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 12.12 | ||||
Total Medicare payments at DRG | $21,288,214,047 | ||||
Total Medicare payments with ICD R9720 - Elevated prostate specific antigen [PSA] | $9,335,034 | ||||
Total Medicare payment per Day at DRG | $1,857 | ||||
Total Medicare payment per Day with ICD R9720 - Elevated prostate specific antigen [PSA] | $1,791 | ||||
Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
Total Medicare payment per Hospitalization with ICD R9720 - Elevated prostate specific antigen [PSA] | $11,892 | ||||
Total Medicare Charges at DRG | $107,155,481,388 | ||||
Total Medicare Charges with ICD R9720 - Elevated prostate specific antigen [PSA] | $48,697,355 | ||||
Avg Charges at DRG | $59,254 | ||||
Avg Charges with ICD R9720 - Elevated prostate specific antigen [PSA] | $62,035 | ||||
Mortality Rate at DRG | 12.11 | ||||
Mortality Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 4.71 | ||||
SNF Discharge Rate at DRG | 27.18 | ||||
SNF Discharge Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 24.08 | ||||
Home Discharge Rate at DRG | 25.81 | ||||
Home Discharge Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 37.32 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 713: TRANSURETHRAL PROSTATECTOMY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 707: MAJOR MALE PELVIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 474,314 | ||||
Total Hospitalizations with ICD R9720 - Elevated prostate specific antigen [PSA] | 483 | ||||
DRG Share of Total Hospitalizations | 1.44 | ||||
% of Total ICD R9720 - Elevated prostate specific antigen [PSA] in DRG | 3.05 | ||||
Avg LOS at DRG | 3.53 | ||||
Avg LOS with ICD R9720 - Elevated prostate specific antigen [PSA] | 3.39 | ||||
Readmission Rate at DRG | 18.03 | ||||
Readmission Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 14.61 | ||||
Unplanned Readmission Rate at DRG | 12.55 | ||||
Unplanned Readmission Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 9.44 | ||||
Total Medicare payments at DRG | $2,312,733,090 | ||||
Total Medicare payments with ICD R9720 - Elevated prostate specific antigen [PSA] | $2,329,644 | ||||
Total Medicare payment per Day at DRG | $1,380 | ||||
Total Medicare payment per Day with ICD R9720 - Elevated prostate specific antigen [PSA] | $1,425 | ||||
Total Medicare payment per Hospitalization at DRG | $4,876 | ||||
Total Medicare payment per Hospitalization with ICD R9720 - Elevated prostate specific antigen [PSA] | $4,823 | ||||
Total Medicare Charges at DRG | $11,559,952,314 | ||||
Total Medicare Charges with ICD R9720 - Elevated prostate specific antigen [PSA] | $10,776,291 | ||||
Avg Charges at DRG | $24,372 | ||||
Avg Charges with ICD R9720 - Elevated prostate specific antigen [PSA] | $22,311 | ||||
Mortality Rate at DRG | 0.22 | ||||
Mortality Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | NA | ||||
SNF Discharge Rate at DRG | 25.96 | ||||
SNF Discharge Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 13.46 | ||||
Home Discharge Rate at DRG | 43.58 | ||||
Home Discharge Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 66.05 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 862: POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 38,827 | ||||
Total Hospitalizations with ICD R9720 - Elevated prostate specific antigen [PSA] | 208 | ||||
DRG Share of Total Hospitalizations | 0.12 | ||||
% of Total ICD R9720 - Elevated prostate specific antigen [PSA] in DRG | 1.31 | ||||
Avg LOS at DRG | 8.58 | ||||
Avg LOS with ICD R9720 - Elevated prostate specific antigen [PSA] | 3.76 | ||||
Readmission Rate at DRG | 27.62 | ||||
Readmission Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 9.05 | ||||
Unplanned Readmission Rate at DRG | 15.85 | ||||
Unplanned Readmission Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 6.53 | ||||
Total Medicare payments at DRG | $555,779,802 | ||||
Total Medicare payments with ICD R9720 - Elevated prostate specific antigen [PSA] | $2,236,335 | ||||
Total Medicare payment per Day at DRG | $1,668 | ||||
Total Medicare payment per Day with ICD R9720 - Elevated prostate specific antigen [PSA] | $2,856 | ||||
Total Medicare payment per Hospitalization at DRG | $14,314 | ||||
Total Medicare payment per Hospitalization with ICD R9720 - Elevated prostate specific antigen [PSA] | $10,752 | ||||
Total Medicare Charges at DRG | $2,652,789,227 | ||||
Total Medicare Charges with ICD R9720 - Elevated prostate specific antigen [PSA] | $6,557,791 | ||||
Avg Charges at DRG | $68,323 | ||||
Avg Charges with ICD R9720 - Elevated prostate specific antigen [PSA] | $31,528 | ||||
Mortality Rate at DRG | 3.06 | ||||
Mortality Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | NA | ||||
SNF Discharge Rate at DRG | 20.78 | ||||
SNF Discharge Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | NA | ||||
Home Discharge Rate at DRG | 32.02 | ||||
Home Discharge Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 84.62 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 885: PSYCHOSES | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 522,791 | ||||
Total Hospitalizations with ICD R9720 - Elevated prostate specific antigen [PSA] | 170 | ||||
DRG Share of Total Hospitalizations | 1.59 | ||||
% of Total ICD R9720 - Elevated prostate specific antigen [PSA] in DRG | 1.07 | ||||
Avg LOS at DRG | 3.14 | ||||
Avg LOS with ICD R9720 - Elevated prostate specific antigen [PSA] | 3.64 | ||||
Readmission Rate at DRG | 17.1 | ||||
Readmission Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 13.75 | ||||
Unplanned Readmission Rate at DRG | 12.62 | ||||
Unplanned Readmission Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 10.0 | ||||
Total Medicare payments at DRG | $2,290,151,156 | ||||
Total Medicare payments with ICD R9720 - Elevated prostate specific antigen [PSA] | $777,747 | ||||
Total Medicare payment per Day at DRG | $1,394 | ||||
Total Medicare payment per Day with ICD R9720 - Elevated prostate specific antigen [PSA] | $1,256 | ||||
Total Medicare payment per Hospitalization at DRG | $4,381 | ||||
Total Medicare payment per Hospitalization with ICD R9720 - Elevated prostate specific antigen [PSA] | $4,575 | ||||
Total Medicare Charges at DRG | $13,619,287,561 | ||||
Total Medicare Charges with ICD R9720 - Elevated prostate specific antigen [PSA] | $4,698,172 | ||||
Avg Charges at DRG | $26,051 | ||||
Avg Charges with ICD R9720 - Elevated prostate specific antigen [PSA] | $27,636 | ||||
Mortality Rate at DRG | 0.18 | ||||
Mortality Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | NA | ||||
SNF Discharge Rate at DRG | 8.57 | ||||
SNF Discharge Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 12.35 | ||||
Home Discharge Rate at DRG | 72.49 | ||||
Home Discharge Rate with ICD R9720 - Elevated prostate specific antigen [PSA] | 68.24 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 66 |
GLENDALE ADVENTIST MEDICAL CENTER | 1509 WILSON TER | GLENDALE | CA | 91206 | 65 |
HARTFORD HOSPITAL | 80 SEYMOUR ST | HARTFORD | CT | 06102 | 63 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. JOSEPH ROBERT WAGNER | 85 SEYMOUR ST | HARTFORD | CT | 06106 | 25 |
Dr. ROSALIA VITERBO | 333 COTTMAN AVENUE | PHILADELPHIA | PA | 19111 | 18 |
Dr. ADAM B SHREWSBERRY | 800 OAK RIDGE TPKE | OAK RIDGE | TN | 37830 | 17 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. JOSEPH ROBERT WAGNER | 85 SEYMOUR ST | HARTFORD | CT | 06106 | 24 |
Dr. ROSALIA VITERBO | 333 COTTMAN AVENUE | PHILADELPHIA | PA | 19111 | 18 |
Dr. ADAM B SHREWSBERRY | 800 OAK RIDGE TPKE | OAK RIDGE | TN | 37830 | 17 |